Advance Search
Volume 37 Issue 11
Nov.  2021
Turn off MathJax
Article Contents
ZHOU Li-hui, PENG Qin, WANG Yuan, . Incidence and mortality of atrial fibrillation in China, 1993 – 2017: an age-period-cohort analysis[J]. Chinese Journal of Public Health, 2021, 37(11): 1672-1676. doi: 10.11847/zgggws1131433
Citation: ZHOU Li-hui, PENG Qin, WANG Yuan, . Incidence and mortality of atrial fibrillation in China, 1993 – 2017: an age-period-cohort analysis[J]. Chinese Journal of Public Health, 2021, 37(11): 1672-1676. doi: 10.11847/zgggws1131433

Incidence and mortality of atrial fibrillation in China, 1993 – 2017: an age-period-cohort analysis

doi: 10.11847/zgggws1131433
  • Received Date: 2020-07-01
    Available Online: 2021-08-12
  • Publish Date: 2021-11-10
  •   Objective   To examine long-time trend in incidence and mortality of atrial fibrillation (AF) and influences of age, period and birth cohort on the incidence and mortality among Chinese population and to provide evidences for developing AF prevention and control strategies.   Methods   The data on AF incidence and mortality from 1993 through 2017 in China were collected from the results of the Global Burden of Diseases Study 2017 (GBD 2017). An R-based web tool from the United States National Cancer Institute for age-period-cohort (APC) analysis was used in this study. The data were arranged to conduct APC analysis for assessing effects of age, period and cohort on AF incidence and mortality.   Results  Increasing trend in the crude and age standardized AF incidence and mortality were observed during the 25-year period in China. The increments during the period of 1993 – 2017 for the crude rate (1/100 000) and age-standardized rate (1/100 000) of AF incidence and mortality for male and female populations were as following: (1) crude AF incidence: 20.61 vs. 42.30 and 24.90 vs. 42.30; (2) age-standardized AF incidence: 30.35 vs. 32.67 and 31.95 vs. 34.18; (3) crude AF mortality: 0.79 vs. 2.32 and 1.89 vs. 4.64; and (4) age-standardized AF mortality: 2.46 vs. 2.78 and 3.78 vs. 3.86. The results of APC analysis demonstrated that the net drift of AF incidence and mortality for male and female populations were all above 0 (AF incidence: 16.595% and 16.527%, AF mortality: 28.570% and 29.026%). Both the incidence and mortality risk of AF increased sharply with the increment of age in a 'J' shaped pattern and the highest AF incidence and mortality risk were observed in populations aged 80 – 89 years. Compared to those during the period of 2003 – 2007, the risk of AF incidence was higher for the periods of 1993 – 2002 and 2008 – 2012 but lower for the period of 2013 – 2017. The risk of AF mortality increased yearly during the 25-year period, and the increase was more dramatic for the years of 2008 – 2017. The risk of AF incidence and mortality for people born between 1976 and 1985 increase with their year of birth in a 'J' shaped exponential pattern.   Conclusion  The incidence and mortality of atrial fibrillation increased persistently during 1993 – 2017 for Chinese population due to impacts of age, period and birth cohort effect.
  • loading
  • [1]
    Guan TJ, Ma J, Li M, et al. Rapid transitions in the epidemiology of stroke and its risk factors in China from 2002 to 2013[J]. Neurology, 2017, 89(1): 53 – 61. doi: 10.1212/WNL.0000000000004056
    [2]
    Healey JS, Oldgren J, Ezekowitz M, et al. Occurrence of death and stroke in patients in 47 countries 1 year after presenting with atrial fibrillation: a cohort study[J]. The Lancet, 2016, 388(10050): 1161 – 1169. doi: 10.1016/S0140-6736(16)30968-0
    [3]
    林红, 张莉梅, 梅丹. 大连市1981 — 2013年居民脑血管病死亡趋势分析[J]. 中国公共卫生, 2014, 30(6): 802 – 805. doi: 10.11847/zgggws2014-30-06-36
    [4]
    周志宏, 陈漠水, 马添翼. 新发房颤患者缺血性卒中风险不同方法评估[J]. 中国公共卫生, 2015, 31(9): 1179 – 1181. doi: 10.11847/zgggws2015-31-09-21
    [5]
    Schnabel RB, Sullivan LM, Levy D, et al. Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study[J]. The Lancet, 2009, 373(9665): 739 – 745. doi: 10.1016/S0140-6736(09)60443-8
    [6]
    Tse HF, Wang YJ, Ahmed Ai-Abdullah M, et al. Stroke prevention in atrial fibrillation – an Asian stroke perspective[J]. Heart Rhythm, 2013, 10(7): 1082 – 1088. doi: 10.1016/j.hrthm.2013.03.017
    [7]
    Wang ZW, Chen Z, Wang X, et al. The disease burden of atrial fibrillation in China from a national cross-sectional survey[J]. The American Journal of Cardiology, 2018, 122(5): 793 – 798. doi: 10.1016/j.amjcard.2018.05.015
    [8]
    GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990 – 2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. The Lancet, 2018, 392(10159): 1789 – 1858. doi: 10.1016/S0140-6736(18)32279-7
    [9]
    Liu SW, Li YC, Zeng XY, et al. Burden of cardiovascular diseases in China, 1990 – 2016: findings from the 2016 global burden of disease study[J]. JAMA Cardiology, 2019, 4(4): 342 – 352. doi: 10.1001/jamacardio.2019.0295
    [10]
    Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional, and national age-sex specific mortality for 264 causes of death, 1980 – 2016: a systematic analysis for the Global Burden of Disease Study 2016[J]. The Lancet, 2017, 390(10100): 1151 – 1210. doi: 10.1016/S0140-6736(17)32152-9
    [11]
    北京世界卫生组织疾病分类合作中心. 国际疾病分类第9次修订本(ICD-9)[M]. 北京: 人民卫生出版社, 1983: 124.
    [12]
    北京协和医院世界卫生组织分类合作中心. 疾病和有关健康问题的国际统计分类第二卷(第10次修订本)[M]. 2版. 北京: 人民卫生出版社, 1997: 145 – 194.
    [13]
    Rosenberg PS, Check DP, Anderson WF. A web tool for age-period-cohort analysis of cancer incidence and mortality rates[J]. Cancer Epidemiology, Biomarkers and Prevention, 2014, 23(11): 2296 – 2302. doi: 10.1158/1055-9965.EPI-14-0300
    [14]
    Li Y, Wu YF, Chen KP, et al. Prevalence of atrial fibrillation in China and its risk factors[J]. Biomedical and Environmental Sciences, 2013, 26(9): 709 – 716.
    [15]
    Lau DH, Nattel S, Kalman JM, et al. Modifiable risk factors and atrial fibrillation[J]. Circulation, 2017, 136(6): 583 – 596. doi: 10.1161/CIRCULATIONAHA.116.023163
    [16]
    Yang XM, Rao ZZ, Gu HQ, et al. Atrial fibrillation known before or detected after stroke share similar risk of ischemic stroke recurrence and death[J]. Stroke, 2019, 50(5): 1124 – 1129. doi: 10.1161/STROKEAHA.118.024176
    [17]
    Chang SS, Dong JZ, Ma CS, et al. Current status and time trends of oral anticoagulation use among Chinese patients with Nonvalvular atrial fibrillation: the Chinese atrial fibrillation registry study[J]. Stroke, 2016, 47(7): 1803 – 1810. doi: 10.1161/STROKEAHA.116.012988
    [18]
    Jiang C, Lan DH, Du X, et al. Prevalence of modifiable risk factors and relation to stroke and death in patients with atrial fibrillation: a report from the China atrial fibrillation registry study[J]. Journal of Cardiovascular Electrophysiology, 2019, 30(12): 2759 – 2767. doi: 10.1111/jce.14231
    [19]
    国家卫生计生委疾病预防控制局. 中国居民营养与慢性病状况报告(2015年)[M]. 北京: 人民卫生出版社, 2015: 48 – 64.
    [20]
    张莲, 殷春悦, 胡善联. 我国心房纤颤的疾病负担[J]. 中国卫生经济, 2013, 32(12): 5 – 7.
    [21]
    刘晓霞, 夏时俊, 马长生. 心房颤动防治的发展与展望[J]. 中华心血管病杂志, 2019, 47(9): 693 – 696. doi: 10.3760/cma.j.issn.0253-3758.2019.09.006
  • 加载中

Catalog

    通讯作者: 陈斌, bchen63@163.com
    • 1. 

      沈阳化工大学材料科学与工程学院 沈阳 110142

    1. 本站搜索
    2. 百度学术搜索
    3. 万方数据库搜索
    4. CNKI搜索

    Figures(5)

    Article views (215) PDF downloads(29) Cited by()
    Proportional views
    Related

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return